IZEA

45e38fe4f37dbb7d7816d217703971713d18d2562e71754a8f

Tuesday, November 25, 2008

Disappointing Results from IGF-1 Clinical Trial

ferncohen.com
Subcutaneous (under the skin) delivery of insulin-like growth factor 1 (IGF-1) does not benefit people with ALS at a dose of 0.5 milligrams per kilogram of body weight, according to a large clinical trial whose results were released today.
Click link above for full article
You can make a tax-deductible donation to ALS research through the Fern Cohen Fund of the ALS Association by clicking the link on the sidebar to the left, which will take you directly to the website, where you can donate online. All the money goes to the ALS Association for research and patient services.
Post a Comment